New York, New York 10065


The purpose of this study is to evaluate prospectively the usefulness of IC-CO2(intraoperative colonoscopy (IC) using carbon dioxide (CO2)) in our colon and rectal surgical practice, coincident with laparoscopic surgery, and assess whether it provides useful information that influences the type of surgical therapy intended. We also wish to further define the safety and extent of bowel distension when using IC-CO2. Furthermore, we wish to evaluate the therapy and technique of using this combined approach to the treatment of colorectal polyps and other localized, benign lesions of the large intestine. In this study, the colonoscope is used both as a diagnostic and therapeutic tool, and is often used in order to avoid a major bowel resection, yet effectively treat localized lesions of the large intestine. The hypothesis of this study is that IC-CO2 will provide useful information which does affect surgical decision making at the time of operation, and that it is safe and does not result in any significant bowel distention during or immediately after the procedure. We additionally hypothesize that certain localized lesions of the intestines may be treated using a combined laparoscopic-IC-CO2 approach to effectively treat the underlying disease, minimize risks to the patient, and avoid a major bowel resection.


Inclusion Criteria: - All patients (male and female) greater than 18 years of age who undergo a laparoscopic surgical procedure that utilizes intra-operative colonoscopy will be approached to participate in this study Exclusion Criteria: - Patients under 18 year of age - Patients with severe Renal Diseases - Ascites - COPD (severe) - Liver insufficiency (severe) with coagulopathy - Dialysis - Sleep Apnea - Patient pregnant - Multiple previous surgeries - Subject is incapable of understanding the informed consent



Primary Contact:

Jeffrey w Milsom, MD
Phone: 212-746 5278

Backup Contact:

Koiana Trencheva, BSN
Phone: 212-746 5241

Location Contact:

New York, New York 10065
United States

Jeffrey W Milsom, MD
Phone: 212-746-5278

Site Status: Recruiting

Data Source:

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.